Financials
| Final results for the year ended 31 December 2024 | Jun. 25, 2025 |
| Full year trading update | Jan. 30, 2025 |
| Interim results for the six months ended 30 June | Sep. 10, 2024 |
| Half-Year Trading Update | Jul. 16, 2024 |
| Final results for the year ended 31 December 2023 | Mar. 19, 2024 |
| Interim results | Sep. 05, 2023 |
| Half-Year Trading Update | Jul. 17, 2023 |
Proxies
| Posting of Annual Report & Notice of AGM | Jun. 27, 2025 |
| Result of AGM | Apr. 25, 2024 |
| Result of AGM | Apr. 26, 2022 |
| Result of AGM | Jun. 03, 2021 |
| Result of AGM | Jun. 30, 2020 |
| Result of AGM | Jun. 27, 2019 |
| Notice of AGM | Jun. 04, 2019 |
Ownership Update
| Grant of share options | Jul. 04, 2025 |
| Holding(s) in Company | Jan. 15, 2025 |
| Holding(s) in Company | Jan. 13, 2025 |
| Holding(s) in Company | Nov. 20, 2024 |
| Grant of share options | Jul. 18, 2024 |
| Holding(s) in Company | Jul. 03, 2024 |
| Holding(s) in Company | Jun. 24, 2024 |
Announcements
| CE & UKCA certification for OrthoPure® XT | Jun. 09, 2025 |
| Conclusion of Strategic Review & Offer Period | Apr. 08, 2025 |
| European patent granted | Mar. 27, 2025 |
| Company update | Mar. 18, 2025 |
| Extended distribution agreement with Arthrex, Inc. | Nov. 26, 2024 |
| Form 8 (OPD) (Tissue Regenix Group Plc) | Nov. 12, 2024 |
| Form 8.3 - Tissue Regenix Group PLC | Nov. 05, 2024 |